Linglong Yin

672 total citations
17 papers, 469 citations indexed

About

Linglong Yin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cell Biology. According to data from OpenAlex, Linglong Yin has authored 17 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Pulmonary and Respiratory Medicine and 4 papers in Cell Biology. Recurrent topics in Linglong Yin's work include Ubiquitin and proteasome pathways (8 papers), Prostate Cancer Treatment and Research (6 papers) and FOXO transcription factor regulation (4 papers). Linglong Yin is often cited by papers focused on Ubiquitin and proteasome pathways (8 papers), Prostate Cancer Treatment and Research (6 papers) and FOXO transcription factor regulation (4 papers). Linglong Yin collaborates with scholars based in China. Linglong Yin's co-authors include Yuchong Peng, Youhong Liu, Bowen Yuan, Qianling Zhu, Tuoyu Cao, Xiaohui Yu, Yingxue Gao, Xuegong Fan, Xiong Li and Yongbo Peng and has published in prestigious journals such as The Journal of Cell Biology, Oncogene and British Journal of Cancer.

In The Last Decade

Linglong Yin

16 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linglong Yin China 10 342 144 122 85 40 17 469
Bowen Yuan China 8 301 0.9× 137 1.0× 103 0.8× 75 0.9× 32 0.8× 14 418
Zhuonan Liu China 8 445 1.3× 132 0.9× 159 1.3× 83 1.0× 23 0.6× 12 529
Ranran Kong China 14 331 1.0× 107 0.7× 189 1.5× 67 0.8× 27 0.7× 37 445
Ján Gurský Czechia 13 271 0.8× 137 1.0× 99 0.8× 54 0.6× 34 0.8× 22 466
Nick A. Kuburich United States 7 260 0.8× 134 0.9× 117 1.0× 55 0.6× 23 0.6× 14 443
Ori Hassin Israel 6 307 0.9× 264 1.8× 136 1.1× 75 0.9× 33 0.8× 8 522
Miaofeng Zhang China 9 421 1.2× 155 1.1× 144 1.2× 61 0.7× 40 1.0× 13 613
Chanida Vinayanuwattikun Thailand 13 214 0.6× 119 0.8× 116 1.0× 92 1.1× 29 0.7× 42 381
Kevin S. Quackenbush United States 12 228 0.7× 219 1.5× 112 0.9× 71 0.8× 47 1.2× 17 423
Shoujie Chai China 10 239 0.7× 204 1.4× 143 1.2× 109 1.3× 25 0.6× 12 431

Countries citing papers authored by Linglong Yin

Since Specialization
Citations

This map shows the geographic impact of Linglong Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linglong Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linglong Yin more than expected).

Fields of papers citing papers by Linglong Yin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linglong Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linglong Yin. The network helps show where Linglong Yin may publish in the future.

Co-authorship network of co-authors of Linglong Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Linglong Yin. A scholar is included among the top collaborators of Linglong Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linglong Yin. Linglong Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Peng, Yuchong, Jingjing Huang, Youhong Liu, et al.. (2024). SKP2 inhibition activates tumor cell-intrinsic immunity by inducing DNA replication stress and genomic instability. British Journal of Cancer. 132(1). 81–92. 5 indexed citations
3.
Peng, Yuchong, Youhong Liu, Yubing Ye, et al.. (2023). PLK1 maintains DNA methylation and cell viability by regulating phosphorylation-dependent UHRF1 protein stability. Cell Death Discovery. 9(1). 367–367. 6 indexed citations
4.
Cao, Tuoyu, Yubing Ye, Youhong Liu, et al.. (2023). AKT1 regulates UHRF1 protein stability and promotes the resistance to abiraterone in prostate cancer. Oncogenesis. 12(1). 1–1. 15 indexed citations
5.
Peng, Yuchong, Rong Tang, Youhong Liu, et al.. (2023). Diosgenin inhibits prostate cancer progression by inducing UHRF1 protein degradation. European Journal of Pharmacology. 942. 175522–175522. 14 indexed citations
6.
Yin, Linglong, et al.. (2023). UHRF1 promotes spindle assembly and chromosome congression by catalyzing EG5 polyubiquitination. The Journal of Cell Biology. 222(11). 9 indexed citations
7.
Deng, Tanggang, Lin Xie, Zhenbin Zhang, et al.. (2023). ATM-Mediated translocation of RanBPM regulates DNA damage response by stabilizing p21 in non-small cell lung cancer cells. Cellular Oncology. 47(1). 245–258. 4 indexed citations
8.
Yin, Linglong, Yubing Ye, Ling Zou, et al.. (2023). AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer. Journal of Experimental & Clinical Cancer Research. 42(1). 204–204. 8 indexed citations
9.
Zhong, Wei, et al.. (2022). FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription. BioMed Research International. 2022(1). 3032590–3032590. 12 indexed citations
10.
Deng, Tanggang, Qianling Zhu, Lin Xie, et al.. (2022). Norcantharidin promotes cancer radiosensitization through Cullin1 neddylation‐mediated CDC6 protein degradation. Molecular Carcinogenesis. 61(8). 812–824. 2 indexed citations
11.
12.
Peng, Yuchong, Youhong Liu, Yingxue Gao, et al.. (2019). USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis. Journal of Experimental & Clinical Cancer Research. 38(1). 468–468. 35 indexed citations
13.
Yu, Xiaohui, Youhong Liu, Linglong Yin, et al.. (2018). Radiation-promoted CDC6 protein stability contributes to radioresistance by regulating senescence and epithelial to mesenchymal transition. Oncogene. 38(4). 549–563. 46 indexed citations
14.
Yin, Linglong, Youhong Liu, Yuchong Peng, et al.. (2018). PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells. Journal of Experimental & Clinical Cancer Research. 37(1). 153–153. 91 indexed citations
15.
Yuan, Bowen, Youhong Liu, Xiaohui Yu, et al.. (2018). FOXM1 contributes to taxane resistance by regulating UHRF1-controlled cancer cell stemness. Cell Death and Disease. 9(5). 562–562. 41 indexed citations
16.
Zhu, Qianling, Zheng Li, Yongbo Peng, et al.. (2017). The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells. Cell Death and Disease. 8(3). e2659–e2659. 100 indexed citations
17.
Liu, Youhong, Yijun Liu, Bowen Yuan, et al.. (2017). FOXM1 promotes the progression of prostate cancer by regulating PSA gene transcription. Oncotarget. 8(10). 17027–17037. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bowen Yuan Breakdown of academic impact, for papers by Zhuonan Liu Breakdown of academic impact, for papers by Ranran Kong Breakdown of academic impact, for papers by Ján Gurský Breakdown of academic impact, for papers by Nick A. Kuburich Breakdown of academic impact, for papers by Ori Hassin Breakdown of academic impact, for papers by Miaofeng Zhang Breakdown of academic impact, for papers by Chanida Vinayanuwattikun Breakdown of academic impact, for papers by Kevin S. Quackenbush Breakdown of academic impact, for papers by Shoujie Chai
Rankless by CCL
2026